Evidence map›Paper›PMID 35301857›Full record

ArticleJournal of the American Heart Association2022

Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction.

Nadia Akhiyat, Vlad Vasile, Ali Ahmad, Jaskanwal Deep Sara, Valentina Nardi, Lilach O Lerman, Allan Jaffe, Amir Lerman

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05107869 (Effect of Plasma Ceramides on Peripheral Vascular Function), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05107869 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Plasma Ceramides on Peripheral Vascular Function

TypeinterventionalSponsorMedical College of WisconsinRan2023 to 2026Enrolled23ConditionsPeripheral Vascular Disease, Lipid Disorder, Endothelial DysfunctionArmsHigh Saturated Fat
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Observational
  17. Article
  18. Review
  19. Ying and Yang of Ceramide in the Vascular Endothelium.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nadia AkhiyatDivision of Internal Medicine Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-2434-2510
Vlad VasileDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0001-5447-8091
Ali AhmadDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0001-9669-8009
Jaskanwal Deep SaraDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.
Valentina NardiDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.
Lilach O LermanDivision of Nephrology and Hypertension Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-3271-3887
Allan JaffeDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0003-1183-3959
Amir LermanDivision of Cardiovascular Disease Department of Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-9446-5313
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Elevated plasma ceramides are independent predictors of cardiovascular disease and mortality in patients with advanced epicardial coronary artery disease. Our understanding of plasma ceramides in early epicardial coronary artery disease, however, remains limited. We examined the role of plasma ceramides in early coronary atherosclerosis characterized by coronary endothelial dysfunction. Methods and Results Participants presenting with chest pain and nonobstructive epicardial coronary artery disease underwent coronary endothelial function. Patients (n=90) demonstrated abnormal coronary endothelial function with acetylcholine (≥20% decrease in coronary artery diameter or ≤50% increase in coronary blood flow). A total of 30 controls had normal coronary endothelial function. Concentrations of plasma ceramide 18:0 (

Indexed as

Coronary Artery DiseaseCeramidesChest PainCoronary CirculationCoronary VesselsEndothelium, VascularHumansCeramidesceramidescoronary artery diseaseendothelial dysfunction

Identifiers

PMID35301857
PMCPMC9075496
OpenAlexW4220991427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.